Prelude Therapeutics Incorporated - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 11/08/2026 | Mar 2026Filed 11/08/2026 | Sep 2025Filed 12/11/2025 | Jun 2025Filed 11/08/2026 | Mar 2025Filed 11/08/2026 | Sep 2024Filed 12/11/2025 | Jun 2024Filed 12/11/2025 | Mar 2024Filed 12/11/2025 |
|---|---|---|---|---|---|---|---|---|
| $5.7 | $4.6 | $6.5 | $0 | $0 | $3 | — | — | |
| −$14 | −$10 | −$20 | −$31 | −$32 | −$32 | −$35 | −$31 | |
| −$0.14 | −$0.13 | −$0.26 | −$0.41 | −$0.42 | −$0.43 | −$0.46 | −$0.42 | |
| 98 | 83 | 76 | 76 | 76 | 76 | 76 | 76 |
Trend